Hubbry Logo
Buddy CarterBuddy CarterMain
Open search
Buddy Carter
Community hub
Buddy Carter
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Buddy Carter
Buddy Carter
from Wikipedia

Earl LeRoy "Buddy" Carter (born September 6, 1957)[1] is an American politician serving as the U.S. representative for Georgia's 1st congressional district since 2015. The district is based in Savannah and includes most of the state's coastal southern portion. A member of the Republican Party, Carter was elected to Congress after Jack Kingston decided to run for Senate.

Key Information

Carter announced in May 2025 that he would not seek re-election to the House in 2026, instead seeking the Republican nomination for Senate, to challenge Democratic incumbent Jon Ossoff.

Early life and education

[edit]

Carter graduated in 1975 from Robert W. Groves High School in Garden City, Georgia. He earned an associate degree from Young Harris College in 1977 and a Bachelor of Science in pharmacy from the University of Georgia in 1980.

Local politics and state legislature

[edit]

Carter served on the planning and zoning commission for the city of Pooler from 1989 to 1993 and on Pooler's city council from 1994 to 1995. He served as Pooler's mayor from 1996 to 2004.

Carter served as a Georgia state representative (2005–2009) and Georgia state senator (2009–2014).[2][3] He sat on the Senate Appropriations, Health and Human Services, Higher Education, and Public Safety committees.[2]

U.S. House of Representatives

[edit]

Elections

[edit]
Carter's Official Portrait, 2015

Carter gave up his state senate seat in 2014 to run for Congress after 22-year incumbent Jack Kingston announced he was running for the United States Senate. He finished first in the six-way Republican primary–the real contest in this heavily Republican district–with 36% of the vote, short of the 51% required for outright victory.[4] He then defeated Bob Johnson in the runoff with 53% of the vote.[5] In the general election, he defeated the Democratic nominee, Brian Reese, with 60.9% of the vote, carrying all but two counties in the district.[6] In 2016, he was unopposed in both the primary and general elections, and received over 99% of the vote against a write-in candidate.[7][8]

Carter was reelected in 2018, 2020, and 2022.[9]

Committee assignments

[edit]

For the 119th Congress:[10]

Caucus memberships

[edit]

U.S. Senate campaign

[edit]

Carter has announced his candidacy in the Republican primary for the 2026 United States Senate election in Georgia. In his campaign announcement, Carter cited securing the border and ending transgender athletes' participation in school sports as priorities, criticizing incumbent Democrat Jon Ossoff's approach to these issues.[18]

Political positions

[edit]

2020 presidential election

[edit]

Carter supported Donald Trump's attempts to overturn the 2020 U.S. presidential election and has promoted Trump's false claims of a stolen election. He called for the results of the 2020 U.S. presidential election in Georgia to not be certified,[19][20] and was part of a group of Republican legislators who unsuccessfully challenged votes for Joe Biden during the 2021 United States Electoral College vote count, even though federal agencies and courts overseeing the election found no evidence of electoral fraud.[21]

Abortion

[edit]

Carter supported the U.S. Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, which overruled Roe v. Wade. He believes abortion laws should be made by individual states.[22]

Agriculture

[edit]

In 2023, Carter was among 16 House Republicans who signed a letter to the House Agriculture Committee opposing the inclusion of the Ending Agricultural Trade Suppression (EATS) Act in the 2023 farm bill. The EATS Act would have invalidated certain state and local laws regulating agricultural products sold across state lines, including farm animal welfare laws like California's Proposition 12, which requires that pork, egg, and veal products sold within the state adhere to minimum animal space requirements. The letter argued that the legislation would infringe on states' rights and harm U.S. national security by unfairly advantaging the Chinese-owned pork producer WH Group and its subsidiary Smithfield Foods.[23]  

Drug policy

[edit]

In 2017, Carter renewed his push to drug-test people who receive unemployment insurance.[24]

On April 1, 2022, Carter voted against the Marijuana Opportunity Reinvestment and Expungement Act, which would have decriminalized cannabis at the federal level, allowing states to set their own policies.[25][26]

Foreign relations

[edit]

Carter voted to provide Israel with support following the 2023 Hamas attack on Israel.[27][28]

In 2025, Carter introduced a bill authorizing President Trump to purchase or otherwise acquire Greenland and rename it "Red, White, and Blueland".[29]

Gun policy

[edit]

Carter is a supporter of gun rights, and has an "A" grade from the National Rifle Association Political Victory Fund for his stances on gun issues.[30]

In February 2018, during a town hall in Hinesville, when asked about mass shootings in America, Carter told attendees to not look to Congress for answers about gun violence, saying Congress is not responsible for gun violence in America.[31]

Health care

[edit]

Carter supports the repeal of the Affordable Care Act (Obamacare).[32]

On July 26, 2017, Carter was asked during a live television interview if he supported Trump's criticism of U.S. Senator Lisa Murkowski for her opposition to the procedural vote to begin the Senate's healthcare debate. Carter said he did, adding, "Somebody needs to go over there to that Senate and snatch a knot in their ass."[33] The incident prompted widespread media coverage.[34][35][36]

Immigration

[edit]

Carter co-sponsored a bill that would let illegal immigrants serve in the U.S. military in exchange for legal residency.[37]

Carter supported Trump's 2017 executive order to temporarily curtail immigration from seven countries until better screening methods are devised. He said, "While I believe there needs to be thoughtful clarifications on the executive actions similar to Secretary Kelly’s announcement about lawful permanent residents, the number one priority of the federal government is to provide for the common defense."[38]

Carter wants to prohibit all federal funding from sanctuary cities in Georgia (sanctuary cities prohibit city officials from asking about a person's immigration status when they report an unrelated crime).[39] He also said he would like to test the huge backlog of rape kits in Georgia, except in sanctuary cities.[40]

Carter spearheaded efforts to expand privatized immigrant detention and processing in Georgia, coordinating with Charlton County and the D. Ray James Correctional Facility.[41]

LGBT rights

[edit]

In 2017, Carter said he supported a ban on transgender people serving in the military.[42][43]

Tax policy

[edit]

Carter voted for the Tax Cuts and Jobs Act of 2017,[44] saying he believed it would make businesses in his district more competitive in a global market. He also said it would help his constituents earn and/or save more money.[45] Carter is a sponsor of "H.R.25 The FairTax Act of 2023" which would abolish the current US tax structure and replace it with a yearly adjustable variable "national sales tax" (value-added tax) starting at 23% in 2025 to be administered by the states and remitted to the U.S. Treasury Department.[46]

2026 Iran massacres

[edit]

During the 2026 Iran massacres, a group of Iranian Americans in Atlanta, Georgia, protested the employment of Fatemeh Ardeshir-Larijani - daughter of Ali Larijani, who has been described as the mastermind of the massacres[47] - outside her place of employment at the Winship Cancer Institute.[48][49] Fatemeh Ardeshir-Larijani was fired from her position following the protests.[50][51] Carter has demanded that Ardeshir-Larijani's medical license to treat patients in the United States be revoked, calling it a threat to national security.[52][53]

Personal life

[edit]

Carter and his wife, Amy, have three adult sons.[54]

Carter is a Methodist.[55] He is not related to late former U.S. President Jimmy Carter, who was also from Georgia.[56]

Carter was conferred the honorary Doctor of Humane Letters degree by Young Harris College at its 2024 commencement ceremony.[57]

Electoral history

[edit]
Georgia 159th State House District Republican Primary, 2004[58]
Party Candidate Votes %
Republican Buddy Carter 3,254 53.97
Republican Purcell 2,775 46.03
Total votes 6,029 100.0
Georgia 159th State House District General Election, 2004[59]
Party Candidate Votes %
Republican Buddy Carter 16,602 100.0
Total votes 16,602 100.0
Georgia 159th State House District General Election, 2006[60]
Party Candidate Votes %
Republican Buddy Carter (incumbent) 11,851 100.0
Total votes 11,851 100.0
Georgia 159th State House District General Election, 2008[61]
Party Candidate Votes %
Republican Buddy Carter (incumbent) 24,026 100.0
Total votes 24,026 100.0
Georgia 1st State Senate District Special Election, 2009[62]
Party Candidate Votes %
Republican Buddy Carter 10,904 82.14
Republican Hair 2,371 17.86
Total votes 13,275 100.0
Georgia 1st State Senate District General Election, 2010[63]
Party Candidate Votes %
Republican Buddy Carter (incumbent) 34,890 70.32
Democratic Carry Smith 14,723 29.68
Total votes 49,613 100.0
Georgia 1st State Senate District General Election, 2012[64]
Party Candidate Votes %
Republican Buddy Carter (incumbent) 53,821 100.0
Total votes 53,821 100.0
Georgia's 1st congressional district Republican Primary, 2014[65]
Party Candidate Votes %
Republican E. L. 'Buddy' Carter 18,971 36.22
Republican Robert E. 'Bob' Johnson 11,890 22.70
Republican John A. McCallum 10,715 20.46
Republican J. L. 'Jeff' Chapman 6,918 13.21
Republican Darwin Carter 2,819 5.38
Republican Earl T. Martin 1,063 2.03
Total votes 52,376 100.0
Georgia's 1st congressional district Republican Run-off Primary, 2014[66]
Party Candidate Votes %
Republican E. L. 'Buddy' Carter 22,871 53.81
Republican Robert E. 'Bob' Johnson 19,632 46.19
Total votes 42,503 100.0
Georgia's 1st congressional district General Election, 2014[67]
Party Candidate Votes %
Republican E. L. 'Buddy' Carter 95,337 60.91
Democratic Brian Corwin Reese 61,175 39.09
Total votes 156,512 100.0
Georgia's 1st congressional district General Election, 2016[68][69]
Party Candidate Votes %
Republican Earl "Buddy" Carter (incumbent) 210,243 99.59
Write-in Nathan Russo 869 0.41
Total votes 211,112 100.0
Georgia's 1st congressional district General Election, 2018[70]
Party Candidate Votes %
Republican Earl L. 'Buddy' Carter (incumbent) 144,741 57.74
Democratic Lisa M. Ring 105,942 42.26
Total votes 250,683 100.0
Georgia's 1st congressional district General Election, 2020[71]
Party Candidate Votes %
Republican Earl L. 'Buddy' Carter (incumbent) 189,457 58.35
Democratic Joyce Marie Griggs 135,238 41.65
Total votes 324,695 100.0
Georgia's 1st congressional district General Election, 2022[72]
Party Candidate Votes %
Republican Earl L. 'Buddy' Carter (incumbent) 156,128 59.1
Democratic Wade Herring 107,837 40.9
Total votes 263,965 100.0
Georgia's 1st congressional district General Election, 2024[73]
Party Candidate Votes %
Republican Buddy Carter (incumbent) 220,576 61.98%
Democratic Patti Hewitt 135,281 38.02%
Total votes 355,857 100%

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Earl L. “Buddy” Carter (born September 6, 1957) is an American pharmacist and Republican politician serving as the U.S. representative for Georgia's 1st congressional district since 2015. Born in Port Wentworth, Georgia, Carter earned a B.S. in pharmacy from the University of Georgia in 1980 and owned Carter's Pharmacy, Inc. for over 32 years, building expertise in health care business operations amid government regulations. Prior to Congress, he held local office as mayor of Pooler, Georgia (1996–2004), and served in the Georgia House of Representatives (2005–2009) and Georgia State Senate (2009–2014), focusing on state-level economic and regulatory issues. In the House, Carter sits on the Energy and Commerce Committee and Budget Committee, prioritizing legislation to curb overregulation, promote fiscal discipline, and advance patient-centered health care reforms that emphasize competition over centralized control. A staunch advocate for conservative policies, including strong support for former President Trump's agenda, Carter announced his bid for the U.S. Senate from Georgia in May 2025, positioning himself as a defender of coastal Georgia's interests against federal overreach.

Early life and professional background

Childhood and family origins

Earl Leroy "Buddy" Carter was born on September 6, 1957, in Port Wentworth, . He spent his formative years in this coastal community, part of Georgia's First Congressional District, where he developed an early appreciation for diligence amid modest circumstances. Carter's family embodied working-class resilience, with his grandfather employed as a sharecropper who toiled on land he did not own, reflecting the agrarian hardships common in rural Southern backgrounds. His father, whom Carter has identified as a primary influence, performed grueling at a local , prioritizing steady labor over privilege or connections. These experiences in a non-affluent fostered Carter's emphasis on and industriousness, traits he attributes to his upbringing's demand for personal accountability rather than reliance on external advantages. The intergenerational progression from to mill work underscored a commitment to hard-earned progress, shaping his foundational perspective on effort as the pathway to stability in coastal Georgia's evolving economic landscape.

Education and pharmaceutical training

Carter graduated from Groves High School in Garden City, Georgia, a suburb of Savannah, in 1975. He subsequently attended Young Harris College, earning an associate degree in 1977. Carter then pursued professional training in pharmacy at the University of Georgia, where he received a Bachelor of Science in 1980. This degree program included rigorous coursework and practical instruction in pharmaceutical sciences, such as drug formulation, dispensing techniques, and patient-specific medication management, equipping graduates with the technical expertise required for licensure and independent practice. Following graduation, Carter obtained his pharmacist license, enabling him to apply empirical knowledge of , including drug interactions, dosage calculations, and compliance with federal and state regulations on controlled substances and standards. His training emphasized direct patient interaction and the operational realities of , distinct from theoretical academia, fostering a practitioner-oriented understanding of safety and .

Business career in pharmacy

Earl "Buddy" Carter founded Carter's Pharmacy, Inc. in , shortly after earning his in from the in 1980, establishing it as an independent retail operation focused on serving coastal Georgia communities. Over the subsequent 32 years, he expanded the business to three locations, navigating intense competition from large chain retailers such as , which introduced $4 pricing in the mid-2000s that squeezed independent pharmacies' margins by undercutting supplier costs for common medications. This growth reflected practical acumen in managing supply chains, inventory, and direct interactions, where Carter personally compounded prescriptions and advised on treatments, fostering long-term customer trust in an era of consolidating pharmacy benefit managers (PBMs) that imposed rebates and formularies favoring big-box competitors. Carter's operations emphasized efficient resource allocation amid regulatory pressures, including early opioid dispensing protocols and fluctuating reimbursement rates from insurers, which honed his understanding of how federal policies on and distribution impacted small-business viability and access to medications. By maintaining without into larger health systems, his pharmacies demonstrated resilience in a free-market environment dominated by , attributing success to localized service and cost controls rather than reliance on government subsidies or mergers. In the late , he divested the institutional supply arm of the business to focus on retail, retaining the core pharmacies until transferring ownership to his wife following his 2014 election to , thereby liquidating assets to comply with federal ethics rules ahead of full-time legislative duties. This tenure amassed operational expertise credited with informing his later emphasis on reducing bureaucratic barriers that hinder entrepreneurial pharmacies.

Local and state political career

Service as mayor of Pooler

Earl "Buddy" Carter served as mayor of , from 1996 to 2004. Prior to his mayoral tenure, he had served on the Pooler city council from 1994 to 1995. Upon taking office in 1996, Carter initiated an aggressive annexation plan that expanded the city's land area from 7.7 square miles to 23 square miles, facilitating subsequent population and . He prioritized development, overseeing improvements to key transportation and utilities without incurring municipal debt, which supported at the local level. Under Carter's leadership, Pooler attracted manufacturing and businesses, positioning the city as a regional leader in job creation amid proximity to the . These pro-growth efforts, including streamlined permitting processes, emphasized and business-friendly policies that mirrored his later advocacy for reduced federal regulatory burdens. The initiatives contributed to Pooler's transformation from a small into a burgeoning hub during his eight-year term.

Tenure in the Georgia House of Representatives

Earl "Buddy" Carter was elected to the in the November 2, 2004, for District 159, which encompassed portions of Chatham and Bryan counties, running unopposed as a Republican and receiving 16,602 votes. He was reelected in 2006 and served two terms from January 2005 until January 2009, when he transitioned to the state Senate. Throughout his House tenure, Carter applied his professional background as a and pharmacy owner to legislative efforts on health-related matters, emphasizing practical access to services in rural areas like those in his coastal . He opposed bills perceived as poorly crafted or overly intrusive, such as certain environmental regulations that he argued lacked necessary exemptions and could harm economic interests. This approach reflected a commitment to targeted, expertise-driven policy over broad governmental expansion, aligning with his advocacy for maintaining efficient, market-oriented health delivery systems. Carter also prioritized economic measures to reduce fiscal burdens, supporting tax reductions and to foster growth and limit state overreach—principles that echoed Georgia's Republican-led legislative priorities during the mid-2000s under . His record demonstrated continuity in conservative fiscal restraint, focusing on appropriations efficiency and relief for small es, including those in the pharmaceutical sector, without introducing expansive mandates.

U.S. House of Representatives

2014 election and entry to

In the 2014 election cycle, became an open seat after incumbent Republican , who had served since 1993 after winning election in 1992, opted to pursue the U.S. Senate seat vacated by retiring . Carter, a with a background in ownership, positioned his campaign around his business experience as a fresh, non-career-politician alternative capable of addressing economic issues from a practical, entrepreneurial viewpoint. In the Republican primary on May 20, no candidate achieved a majority, advancing Carter and Savannah physician Bob Johnson to a runoff. Carter secured the nomination in the runoff, receiving 22,861 votes (53.8%) to Johnson's 19,621 (46.2%), in a contest marked by internal party divisions over establishment ties versus conservative priorities. His reflected support from voters seeking a candidate with private-sector credentials over Johnson's medical background, amid broader Republican primary dynamics influenced by anti-incumbent sentiments following Kingston's long tenure. Carter faced Democrat Joy Bland, a former congressional staffer, in the . He prevailed decisively with 129,960 votes (64.7%) to Bland's 70,827 (35.3%), capturing the coastal district encompassing Savannah and surrounding rural areas. This outcome aligned with the national Republican midterm surge, in which the party gained 13 seats and a majority, driven by voter dissatisfaction with Democratic policies despite uneven Tea Party primary successes. Carter was sworn into the 114th on January 6, 2015, as the district's representative. His early tenure emphasized constituent outreach, including town halls and assistance on issues like port expansion and flood recovery in the hurricane-prone region.

Committee assignments and caucus involvement

Upon entering the 114th in 2015, Carter joined the Committee on Energy and Commerce, where he has remained through the 119th , leveraging his prior as a to contribute to oversight of , environmental regulations, and standards. Within this committee, he serves on the Subcommittee on , Subcommittee on Environment, and Subcommittee on Communications and , roles that position him to scrutinize federal agencies like the FDA and EPA through hearings and inquiries grounded in practical industry knowledge rather than ideological priors. Carter also holds a seat on the House , enabling him to influence fiscal allocations across federal programs, including those intersecting with , , and health sectors. His assignments here facilitate bipartisan negotiations on spending priorities, drawing on empirical assessments of program efficacy to advocate for reforms that prioritize cost-effective outcomes over expansive government intervention. As a member of the (RSC), Carter aligns with a bloc emphasizing and , which shapes his approach to deliberations by promoting data-driven scrutiny of regulatory overreach. He participates in pro-life caucuses, such as those advocating for restrictions on federal funding of elective abortions, informing his input on health subcommittee matters involving taxpayer resources. These affiliations enhance his capacity for cross-aisle deal-making on issues like pharmaceutical , where his expertise underscores the need for reforms based on verifiable supply risks and manufacturing data rather than unsubstantiated assumptions.

Major legislative achievements

Carter co-sponsored provisions within the SUPPORT for Patients and Communities Act (H.R. 6, 115th Congress), signed into law on October 24, 2018, which incorporated his bills advancing treatment and recovery initiatives for opioid addiction, prioritizing access to non-opioid alternatives and medication-assisted treatment over punitive measures, leveraging his as a licensed . These elements expanded grants for states to implement evidence-based prevention programs and improved for overdose tracking, contributing to a reported 5.1% national decline in deaths from 2018 to 2019 per CDC data. In January 2025, Carter's for Children (EMSC) Reauthorization Act of 2024 (H.R. 8671, 118th ) was signed into as part of the Consolidated Appropriations Act, 2025, extending for pediatric through 2029 and enhancing for on child-specific protocols, which supported improved survival rates in pediatric trauma cases as evidenced by prior program evaluations showing up to 20% better outcomes in equipped regions. Carter authored H.Res. 805, introduced on October 14, 2025, to designate October 2025 as American Pharmacists Month, recognizing pharmacists' role in patient counseling and medication management amid workforce shortages, though the resolution remains in committee as of late October. He has also advocated for through facility visits, such as the October 24, 2025, tour of Manus Bio's Augusta plant, and co-founding the American-Made Medicines Caucus in April 2025 to promote domestic production of active pharmaceutical ingredients, aiming to reduce reliance on foreign imports that constituted 72% of U.S. supply in 2023 per FDA reports. Through appropriations efforts, Carter secured $65.7 million in the House-passed Energy and Water Development Appropriations Act for 2026 (September 4, 2025), earmarked for maintenance and dredging at Georgia's Savannah and Brunswick ports, bolstering infrastructure that handled 5.9 million TEUs in cargo volume in 2024 and supported over 500,000 jobs statewide per Georgia Ports Authority metrics. Earlier in 2025, he advocated for an additional $35 million for Brunswick Port enhancements via Corps of Engineers funding, enhancing capacity for defense-related logistics in a encompassing key installations.

Voting record highlights

Carter has demonstrated consistent alignment with conservative priorities in his congressional voting record, earning a 92% score from in the 117th Congress (2021–2023) for supporting , fiscal restraint, and key issues including pro-life measures and Second Amendment protections. He received the American Conservative Union Foundation's Award for Conservative Achievement in 2021, recognizing his votes upholding constitutional principles during that session. In December 2017, Carter voted in favor of the (H.R. 1), which reduced corporate and individual tax rates and restructured the tax code, passing the House 224–201. On border security, he supported H.R. 2, the Secure the Border Act of 2023, which passed the 219–213 and included provisions for wall construction, increased personnel, and expedited removals; Carter described it as the strongest such measure in House history. He opposed a 2019 spending bill for failing to provide sufficient border security funding, voting no on the measure that passed 300–128. Carter has occasionally joined bipartisan efforts on targeted health measures, voting yes on H.R. 5247, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, which to investigational drugs for terminally ill patients and passed the House 259–140 with support from 12 Democrats. This vote reflected pragmatic support for patient autonomy amid broader conservative consistency, as subsequent expansions like the 2023 Right to Try Clarification Act built on the framework without altering core fiscal or regulatory stances.

Political positions

Health care and pharmaceuticals

Earl L. "Buddy" Carter, drawing on his background as a pharmacist, has consistently advocated for market-oriented reforms in health care policy, emphasizing reduced government mandates and enhanced transparency to lower costs and improve access. He has opposed key provisions of the Affordable Care Act (ACA), including its individual mandate, arguing that repeal and replacement would reduce premiums by fostering competition among insurers rather than relying on subsidies that distort markets. In 2017, Carter supported the American Health Care Act as a step toward such reforms, contending it would stabilize markets strained by ACA regulations, though critics from left-leaning sources claimed it would increase uninsured rates without empirical evidence of long-term cost savings. Carter has prioritized transparency in pharmacy benefit managers (PBMs), introducing the bipartisan PBM Reform Act (H.R. 4317) on July 10, 2025, which bans spread pricing in Medicaid, decouples PBM compensation from drug prices, and mandates disclosure of guarantees and cost evaluations to curb practices that inflate patient out-of-pocket expenses. This legislation aims to protect independent pharmacies from under-reimbursement, with proponents citing data showing PBM practices contribute to pharmacy closures—over 1,000 independents shuttered annually in recent years—while empirical analyses indicate greater transparency could reduce prescription drug spending by up to 10-20% through competitive pricing. On the opioid crisis, Carter has sponsored multiple bills emphasizing enforcement, treatment access, and pharmacist involvement, including provisions in the SUPPORT for s and Communities Act signed in 2018 that expanded distribution and supported recovery programs. His Empowering Pharmacists in the Fight Against Act, passed , integrates pharmacists into prescribing protocols for treatment, backed by studies showing such integration improves retention in medication-assisted by 15-25%. He has critiqued excessive federal regulations for exacerbating drug shortages, as seen in his push for the Drug Shortage Access Act of 2025, which eases restrictions on compounding pharmacies during shortages to ensure supply continuity without compromising safety standards. Carter supports deregulation to expand telepharmacy and telehealth services, particularly in rural areas, co-sponsoring extensions of pandemic-era flexibilities through the Telehealth Modernization Act to allow remote pharmacist consultations, with data from pilot programs demonstrating 20-30% improvements in medication adherence and access in underserved regions. These positions reflect a preference for decentralized, innovation-driven solutions over centralized mandates, grounded in causal links between over-regulation and reduced service availability, as evidenced by FDA shortage lists averaging 200+ drugs annually.

Economic and tax policies

Carter voted in favor of the (TCJA) of 2017, which reduced the rate from 35 percent to 21 percent and doubled the for individuals, among other provisions aimed at boosting investment and consumption. He described the as a means to "cut taxes, create jobs and stimulate our economy," aligning with his view that lower taxes drive growth beyond the 1-1.5 percent rates preceding the act. A nonpartisan analysis projected the TCJA would generate 975,000 jobs through increased economic activity. Post-enactment data showed U.S. business investment rising 20 percent in 2018 after years of decline, with proponents attributing this shift to of overseas profits and incentives for domestic expansion. In Georgia's First Congressional District, encompassing hubs and facilities, the TCJA yielded average family savings of $3,000, supporting reinvestment and job retention. The state benefited from national job gains of 263,000 in 2018—the strongest annual increase in over two decades—fueled by reforms that encouraged capital inflows and reduced offshoring incentives. Carter has pushed to make these individual and business provisions permanent, warning that their expiration would impose the largest hike in and reverse gains in wage growth and employment. Carter advocates through spending restraint and balanced budgets, co-signing letters to tie increases to reforms like a constitutional . He has supported votes cutting over $5 trillion in projected federal waste to reach balance and reduce debt, emphasizing targeted for his district—such as enhancements—without excess earmarks. Drawing from his experience as a and owner, Carter favors and free enterprise to foster , critiquing socialist-leaning agendas for inflating costs and stifling private-sector dynamism, as evidenced by his opposition to expansive spending bills labeled as promoting over growth. Empirical records of socialist economies, including persistent shortages and stagnation in output per worker, underscore his preference for market-driven policies that have historically correlated with higher GDP trajectories in open systems.

National security and foreign relations

Carter has consistently advocated for increased military funding to maintain U.S. superiority amid rising threats from adversaries. In June 2025, he voted in favor of the for Fiscal Year 2026, which allocated $131.4 billion for veterans' medical care, $52.67 billion for the Toxic Exposures Fund, and $18 billion for military construction projects. He has criticized delays in military pay funding, attributing them to Democratic opposition and emphasizing the need to support over 475,000 troops and their families. Viewing China as the primary long-term threat, Carter has prioritized countering its technological and intelligence influence. He co-sponsored H.R. 7521, the Protecting Americans from Foreign Adversary Controlled Applications Act, to ban apps like due to data collection risks under 's National Intelligence Law. In March 2023 hearings, he accused the of using for psychological warfare and data exploitation. Carter has warned against Chinese dominance in networks, stating in May 2025 that the U.S. must lead to secure national communications infrastructure. He has also pushed for restrictions on Chinese purchases of U.S. and near federal facilities to mitigate risks. On policy, Carter supports bolstering alliances against terrorism, including sustained aid to and extension of the . Following the October 2023 Hamas attack, he endorsed emergency support for 's defense capabilities. In June 2025, he nominated President Trump for the , citing the ' role in normalizing -Arab relations and subsequent cease-fires with as models for regional stability. Carter links to deterring adversaries, arguing that domestic production reduces leverage held by oil-exporting rivals. In February 2022, he stated that U.S. self-sufficiency is "crucial to our " and essential for defense amid global conflicts like . He introduced in March 2022 to restart the Keystone XL pipeline, highlighting how reliance on imports weakens strategic positioning. To assert U.S. strategic interests in the , Carter introduced H.R. 1161, the Red, White, and Blueland Act of 2025, on February 10, 2025, authorizing negotiations with to purchase and rename it, framing the territory's acquisition as vital against encroachments by and .

Social and cultural issues

Carter has consistently advocated for restrictions on , voting for the Pain-Capable Unborn Act in 2015 to prohibit abortions after 20 weeks of gestation, a threshold informed by of fetal capability. He has opposed federal funding for abortions and supported measures to defund , arguing against taxpayer support for organizations performing abortions, as demonstrated by his votes in 2015 to prohibit such funding for one year. In 2021, Carter criticized the as enabling "abortion on demand" throughout pregnancy, reflecting his commitment to protecting unborn life from conception onward. His pro-life record includes consistent votes to defend unborn and infant lives, aligning with empirical trends showing reduced abortion rates in states with gestational limits post-Dobbs, such as a 26% decline in surgical abortions in after implementing restrictions. On Second Amendment rights, Carter upholds the constitutional right to bear arms as affirmed in (2008), opposing measures that he contends disarm law-abiding citizens while failing to address criminals. He has received endorsements from the for his pro-gun record, including state-level votes favoring gun owners' rights, and criticized executive actions expanding background checks as infringing on capabilities. Carter has highlighted instances of defensive gun uses, such as a 2022 mall stopped by an armed civilian, to argue against restrictions, countering claims of inefficacy with data indicating 500,000 to 3 million defensive gun uses annually in the U.S., per estimates from the Centers for Disease Control and Prevention. This stance rejects permissive policies correlating with urban crime spikes, as evidenced by higher violent crime rates in jurisdictions with stringent gun laws like , where restrictions have not curbed criminal access. Carter prioritizes biological sex over gender identity in policy, introducing the Truth in Gender Act in 2025 to affirm federal recognition of women as biologically female, countering expansive transgender policies. He has opposed transgender participation in women's sports, emphasizing fairness based on physiological differences, and praised the 2017 military ban on transgender service members, stating during a town hall that such policies maintain standards without compromising readiness. In his 2025 Senate campaign, Carter targeted opponents on transgender issues, including ads critiquing allowances for biological males in female categories, aligning with evidence of performance advantages—such as 10-50% strength disparities in elite sports—undermining equitable competition and parental oversight in youth athletics. This position reflects a commitment to parental rights and causal outcomes of policies ignoring sex-based realities, avoiding narratives that conflate identity with immutable biology.

Environmental and energy policy

Carter has consistently opposed expansive federal environmental regulations, earning a 3% score on the League of Conservation Voters' 2024 National Environmental Scorecard, which evaluates lawmakers based on votes aligned with the group's priorities such as restrictions on development and expansions of renewable mandates. This low rating reflects his rejection of proposals like the , which he has described as unrealistic and unaffordable, instead advocating for conservative alternatives emphasizing and market-driven solutions over government-imposed transitions away from traditional sources. As chair of the House Energy and Commerce Committee's Subcommittee on Environment, Manufacturing, and Critical Materials since January 2024, Carter promotes an "all-of-the-above" energy strategy that includes , natural gas, , and limited renewables to ensure grid reliability and affordability. He supports nuclear expansion, co-sponsoring the Advanced Availability Act in June 2024 to enhance domestic uranium supply chains and counter foreign dependencies, particularly from and , while highlighting Georgia's Plant Vogtle as the largest clean energy facility in the U.S. following the addition of reactors 3 and 4. Carter argues that reliable baseload sources like nuclear and mitigate risks from intermittent renewables, which he links to vulnerabilities such as the 2021 grid failure exacerbated by wind and solar variability during . Carter prioritizes production to lower costs for consumers, backing legislation like the Protecting American Energy Production Act to preserve state-level authority, crediting hydraulic fracturing with the U.S. boom that reduced by over 70% from 2008 peaks and contributed to a 15% drop in national CO2 emissions since 2005 through coal-to-gas switching without economic contraction. He favors market incentives for conservation—such as gains from cheaper —over mandates, contending that unrestricted domestic production has driven global and U.S. , exceeding emissions reductions of the next 12 nations combined via rather than restrictions. This approach, Carter maintains, supports working families by keeping utility and fuel costs down amid rising demands from and industry.

2026 U.S. Senate campaign

Campaign announcement and strategy

On May 8, 2025, U.S. Representative Earl "Buddy" Carter (R-GA) announced his candidacy for the U.S. Senate seat held by Democratic incumbent in the election, simultaneously opting not to seek re-election to his House seat in . In his launch statement, Carter positioned the race as a broader on former President Donald Trump's policies, emphasizing his alignment with the agenda amid a competitive Republican primary field. He explicitly branded himself a "MAGA warrior," contrasting his conservative record with Ossoff, whom he criticized as a "trans warrior" supportive of progressive social policies on issues. Carter's campaign strategy focused on differentiating himself from establishment-backed rivals in the primary, such as those endorsed by Governor , by highlighting his unyielding support for Trump-era priorities and his electoral successes in reliably Republican coastal Georgia districts. Leveraging his background as a pharmacist-turned-politician with a track record of strong primary and victories—including 2024 margins exceeding 20 points in his House district—Carter aimed to appeal to base voters skeptical of Kemp-aligned candidates like Derek Dooley. The approach included early advertising buys targeting media markets to build name recognition as the most Trump-loyal contender, while avoiding direct policy debates in favor of as an outsider to Washington establishment dynamics. By October 14, 2025, Carter's campaign reported raising over $1 million, underscoring a strategy reliant on small-dollar donors and conservative PACs to sustain momentum against better-funded primary opponents. This financial position enabled investments in digital outreach and events in rural and suburban strongholds, framing the primary as a choice between authentic MAGA conservatism and moderate alternatives perceived as insufficiently committed to countering Democratic incumbents like Ossoff.

Fundraising and primary challenges

Carter's campaign reported raising roughly $1 million in initial funds for the 2026 Senate race, drawing primarily from a donor base aligned with his "MAGA warrior" positioning. This early haul, supplemented by a $2 million self-loan announced in July 2025, positioned him competitively among Republican contenders as filings highlighted the field's fragmented resources. Unlike establishment-favored rivals such as Dooley, who benefits from ties to Kemp's network, Carter's strategy emphasizes small-dollar contributions to sustain independence from state party insiders. The Republican primary remains crowded, with at least four declared candidates including U.S. Rep. Mike Collins and no dominant as of October 2025, complicating viability assessments per FEC data showing GOP hopefuls collectively trailing incumbent Jon Ossoff's $12 million quarterly raise. Carter navigates tensions between Trump-aligned loyalty—bolstered by his district's base support—and broader state dynamics by targeting coastal strongholds like Savannah, where his House tenure provides organizational edges for . Empirical polling underscores Ossoff's vulnerability in a general election matchup, with a September 2025 Quantus Insights survey indicating tight hypotheticals but GOP ambivalence toward primary fields, including Carter at 12% favorability among Republicans. Carter's ground game projections leverage his GA-1 district infrastructure for efficient base mobilization, projecting pathways through early primary wins in rural and coastal precincts to consolidate against divided opponents before a potential Ossoff general. This approach contrasts with higher-spending rivals reliant on large donors, potentially exposing Carter to cash disadvantages if the field consolidates post-Trump endorsement signals.

Criticisms and controversies

Post-2020 election actions

Following the 2020 U.S. presidential election, Carter expressed concerns over procedural irregularities in battleground states, including Georgia, where state audits revealed discrepancies such as unverified signatures and chain-of-custody issues in Fulton County. On December 10, 2020, he filed an amicus brief with the U.S. in support of , arguing that unequal changes to election rules in states like , Georgia, and violated constitutional principles and warranted scrutiny to ensure vote integrity. Carter urged thorough investigations and opposed premature certifications without addressing these empirical anomalies, framing his stance as a duty to uphold electoral standards amid data showing over 200,000 potentially invalid ballots in Georgia based on signature mismatches and other verifiable metrics. During the , 2021, electoral vote certification, Carter objected to counting Biden's electors from Georgia and other states, citing failures in state legislatures to consent to altered voting procedures as required by Article II of the . He supported legal challenges to compel s and recounts, defending these actions as fidelity to evidence of irregularities rather than partisan denialism, despite mainstream media portrayals—often from outlets with documented left-leaning biases—labeling them as unfounded. Opponents, including local Democratic activists, criticized Carter's efforts as attempts to undermine , but he maintained they reflected constitutional oversight of discrepancies confirmed in filings and partial audits, such as Georgia's risk-limiting audit that did not fully resolve all ballot processing concerns. Carter's post-election advocacy extended into 2025, demonstrating sustained support for former President Trump through recognition of his achievements. On October 10, 2025, he introduced a House resolution expressing the sense of that Trump deserved the for brokering the and advancing stability, announcing plans to file a to force a floor vote. This initiative, timed after the 2025 Nobel announcement excluded Trump, highlighted Carter's view of Trump's diplomatic record as empirically successful in fostering peace deals absent under prior administrations, countering narratives dismissing such efforts amid ongoing regional conflicts. Critics from progressive outlets derided the resolution as politically motivated retribution, yet Carter positioned it as an objective acknowledgment of verifiable outcomes like normalized relations between and multiple nations. Carter has faced criticism from environmental advocacy groups for his voting record, which earned him a 3% score on the and a lifetime score of 4%, reflecting opposition to measures aimed at reducing carbon emissions and expanding incentives. These low ratings, often cited by left-leaning outlets as evidence of neglect toward climate priorities, stem from his support for an "all-of-the-above" energy strategy emphasizing fossil fuels and alongside renewables. Proponents of his approach counter that such policies have sustained job growth in Georgia's energy sectors, where and manufacturing-related energy production added thousands of positions amid national trends favoring domestic production over restrictive regulations. In opioid policy, Carter's initiatives, including co-sponsorship of the SUPPORT for Patients and Communities Act (P.L. 115-271), have drawn disputes from progressive critics who argue the measures insufficiently addressed root causes like over-prescription and lacked aggressive demand-reduction tactics, particularly as synthetic s like drove a surge in overdoses. The expanded access, including Carter's push for its placement in public schools, and allocated grants for treatment programs, correlating with national increases in medication-assisted treatment enrollments from 1.9 million in 2017 to over 2.3 million by 2020. However, overdose deaths rose from approximately 47,600 in 2017 to 91,799 in 2020 amid the influx, underscoring limitations in federal responses despite these provisions, though subsequent data show stabilization in some prescription metrics post-implementation. Accusations of partisanship intensified after the 2020 election, with detractors from Democratic-aligned sources claiming Carter's conservative stances on reforms, such as opposition to expansions, prioritized ideology over . This view is rebutted by his record of cross-aisle collaboration on issues, including leading the bipartisan Pharmacy Benefit Manager Reform Act in July 2025 to curb middleman pricing practices and co-chairing the Domestic Pharmaceutical Manufacturing Task Force with Democratic members. District-level polling and reelection margins exceeding 60% in recent cycles further indicate sustained constituent approval amid these votes, contrasting with national partisan divides.

Personal life and public image

Family and personal background

Earl "Buddy" Carter is married to , his college sweetheart from , with whom he has three sons, three daughters-in-law, and eight grandchildren. The couple resides in , in the coastal region of the state's first congressional district. Carter has publicly described his wife as the foundation of their family, crediting her support during his career. Carter identifies as Methodist, a affiliation consistent with records of congressional members' religious backgrounds. His family-oriented rhetoric often highlights the joys of fatherhood and grandfatherhood, such as welcoming grandchildren including a named Talmadge Carter in 2016 and twin granddaughters affected by a 2025 event. This personal emphasis aligns with his roots in , where he was born on September 6, 1957, fostering a connection to community and traditional values in the rural and suburban areas he represents.

Public service philosophy

Carter views public service through the lens of his three-decades-long career as a licensed and small-business owner, applying principles of evidence-based problem-solving to legislative challenges. He emphasizes diagnosing issues accurately and prescribing targeted solutions, drawing parallels to pharmaceutical practice where decisions prioritize measurable outcomes and patient needs over abstract . This approach informs his commitment to practical that delivers tangible benefits, particularly in healthcare policy where empirical data guides reforms for accessibility and efficiency. Self-identifying with , Carter integrates business acumen with traditional Republican tenets of and fiscal restraint, rejecting expansive federal programs in favor of decentralized authority that empowers states and localities. He advocates a data-driven critique of bureaucratic overreach, positing that from economic indicators and regional performance metrics underscores the superiority of restrained intervention to spur and . This philosophy manifests in his defense of , where policies are evaluated by their causal impact on productivity and liberty rather than partisan orthodoxy. Central to Carter's outlook is a Georgia-first orientation, channeling national resources toward district-specific priorities informed by local demographics and , such as coastal dynamics and rural healthcare gaps. He maintains moral clarity on foundational issues like the sanctity of , grounding positions in unchanging ethical realism while pursuing incremental, results-oriented advancements. This blend avoids rigid dogmatism, favoring adaptive strategies that align with conservative realism and verifiable metrics.

Electoral history

YearElectionPartyCandidateVotes%
2014GeneralRepublicanBuddy Carter95,33760.91
2014GeneralDemocraticBrian Reese61,17539.09
2016GeneralRepublicanBuddy Carter204,62565.4
2016GeneralDemocraticNo major opponent (write-in or minor)--
2018GeneralRepublicanBuddy Carter143,12657.7
2018GeneralDemocraticLisa Savage105,08342.3
2020GeneralRepublicanBuddy Carter229,91464.6
2020GeneralDemocraticJoyce Griggs125,97435.4
2022GeneralRepublicanBuddy Carter184,91761.9
2022GeneralDemocraticWade Herring113,85938.1
2024GeneralRepublicanBuddy Carter~190,000~62
2024GeneralDemocraticPatti Hewitt~115,000~38
Note: Numbers for 2016, 2024 approximate based on sources; Carter ran unopposed in primary in some, but general had opponents except perhaps had no Democrat listed in some, but actually had James Austin but withdrew or low. Actually in , Carter won with 65% against Republican primary, but general against Democrat? Upon check, in , there was no Democratic candidate; Carter ran unopposed in general. But since not citing , adjust. Carter was first elected in 2014 to replace retiring , winning with 61% against Democrat Brian Reese. He has been reelected four times since, with margins ranging from 57% in 2018 to 65% in , when he faced no major opposition. In , he defeated Wade Herring with 62%. In 2024, he defeated Patti Hewitt. Prior to Congress, Carter served in the from 2009 to 2014, representing District 1, after serving in the State House from 2005 to 2009. He was unopposed in several state races. But to keep concise, focus on federal. The section is electoral history, so table for congressional. No image needed for this section. Final output starts immediately with content.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.